45 CFR § 180 compliance
F · 50
This hospital published little of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
○Discounted cash price: below assessment threshold
○Payer-specific negotiated rates: below assessment threshold
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
3,100
Insurances with rates
7
CPT / HCPCS codes
0
Most expensive procedures (gross)
2502772
—
INVEGA SUSTENNA 234 MG/INJ
Gross
$4,068
50458056401
—
INVEGA SUST INJ 156MG/ML
Gross
$4,068
9180900
—
COMP PSYCHOLOGICAL ASSESS
Gross
$4,050
9180950
—
PSYCH CONSULT OTHER>4 HRS
Gross
$4,050
9180750
—
PSYCH TESTING NE BATTERY
Gross
$4,039
2501011
—
ARISTADA ER 662MG INJ
Gross
$2,902
65757040203
—
ARISTADA ER 662MG (aripiprazole lauroxil) IM suspensionextended rel syring
Gross
$2,902
5005883
—
NEUROPSYCH.EVALUATION 7HR
Gross
$2,718
1002500
—
NRI/2 BED
Gross
$2,600
1003001
—
NRI BEHAVIORAL R/B
Gross
$2,600
5505883
—
NEUROPSYCH EVAL
Gross
$2,571
2502771
—
INVEGA SUSTENNA 156 MG/ML
Gross
$2,333
9180850
—
PSYCH CONSULT OTHER<4 HRS
Gross
$2,030
1001001
—
PSTAY/2 BED
Gross
$1,600
1004001
—
TLC R/B PROGRAM
Gross
$1,600
1004002
—
RESIDENTIAL R/B PROGRAM
Gross
$1,600
5006883
—
NEUROPSYCH TESTING
Gross
$1,366
2501006
—
ZYPREXA REL INJ 300MG
Gross
$1,339
2506298
—
FORTEO 750MCG/3ML
Gross
$1,113
2503792
—
GOLYTELY SOL 4000 ML
Gross
$1,072
2503854
—
RISPERDAL INJ 50 MG/2ML
Gross
$906
2500481
—
XIIDRA 5% OPHTH DROPS
Gross
$874
24208091105
—
XIIDRA 5% OPHTH (lifitegrast) dropperette
Gross
$874
2506192
—
REGRANEX GEL 0.01%
Gross
$830
9180700
—
PSYCH TESTING ASSESSMENT
Gross
$827
3000590
—
HEAVY METALS PROFILE 1
Gross
$821
9180200
—
PSYCH TESTING-ADMIT-BEH
Gross
$742
9180650
—
PSYCH TESTING-ABS-RC:2
Gross
$742
3003520
—
PROGRAF LEVEL
Gross
$730
2503700
—
RISPERDAL INJ 37.5 MG/2
Gross
$680
2506327
—
MEGACE ES 625MG/5ML SUS
Gross
$669
3007902
—
HEP C VIRAL RNA GENO 1 NS5A DRUG RESISTANT
Gross
$653
2506402
—
ADVAIR DISK MIS 500/50
Gross
$536
3007535
—
HIV QT PCR (HIV 1 RNA PCR)
Gross
$516
2503853
—
RISPERDAL INJ 25MG/2ML
Gross
$453
3007901
—
HIV GENOTYPE SEQUENCEING
Gross
$450
5005881
—
MMPI-2
Gross
$440
5005882
—
NEUROPSYCH. EVAL. 1 HR.
Gross
$439
9180550
—
PSYCH TESTING-HRC20
Gross
$430
9180600
—
PSYCH TESTING-BNCE
Gross
$430
9180800
—
CLINICAL FILE REVIEW
Gross
$430
3006235
—
EXTRACTABLE NUCL ANTIGEN
Gross
$424
2507446
—
VICTOZA INJ 18MG/3ML
Gross
$412
00480366719
—
VICTOZA 18MG/3ML SUBQ PEN (LIRAGLUTIDE)
Gross
$412
2506246
—
ADVAIR DISK NR MIS 250/50
Gross
$406
3004403
—
TESTOSTERONE LEVEL
Gross
$402
2507519
—
NAYZILAM 5MG/0.1ML SOLN
Gross
$379
50474050015
—
NAYZILAM 5MG/0.1ML SOLN
Gross
$379
2507098
—
SYMBICORT 160/4.5MCG
Gross
$371
2506667
—
XIBROM SOL 0.09%
Gross
$348
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 2502772 | INVEGA SUSTENNA 234 MG/INJ | $4,068 | — | — | — | 0 |
| 50458056401 | INVEGA SUST INJ 156MG/ML | $4,068 | — | — | — | 0 |
| 9180900 | COMP PSYCHOLOGICAL ASSESS | $4,050 | — | — | — | 0 |
| 9180950 | PSYCH CONSULT OTHER>4 HRS | $4,050 | — | — | — | 0 |
| 9180750 | PSYCH TESTING NE BATTERY | $4,039 | — | — | — | 0 |
| 2501011 | ARISTADA ER 662MG INJ | $2,902 | — | — | — | 0 |
| 65757040203 | ARISTADA ER 662MG (aripiprazole lauroxil) IM suspensionextended rel syring | $2,902 | — | — | — | 0 |
| 5005883 | NEUROPSYCH.EVALUATION 7HR | $2,718 | — | — | — | 0 |
| 1002500 | NRI/2 BED | $2,600 | — | — | — | 8 |
| 1003001 | NRI BEHAVIORAL R/B | $2,600 | — | — | — | 22 |
| 5505883 | NEUROPSYCH EVAL | $2,571 | — | — | — | 0 |
| 2502771 | INVEGA SUSTENNA 156 MG/ML | $2,333 | — | — | — | 0 |
| 9180850 | PSYCH CONSULT OTHER<4 HRS | $2,030 | — | — | — | 0 |
| 1001001 | PSTAY/2 BED | $1,600 | — | — | — | 8 |
| 1004001 | TLC R/B PROGRAM | $1,600 | — | — | — | 8 |
| 1004002 | RESIDENTIAL R/B PROGRAM | $1,600 | — | — | — | 22 |
| 5006883 | NEUROPSYCH TESTING | $1,366 | — | — | — | 0 |
| 2501006 | ZYPREXA REL INJ 300MG | $1,339 | — | — | — | 0 |
| 2506298 | FORTEO 750MCG/3ML | $1,113 | — | — | — | 0 |
| 2503792 | GOLYTELY SOL 4000 ML | $1,072 | — | — | — | 0 |
| 2503854 | RISPERDAL INJ 50 MG/2ML | $906 | — | — | — | 0 |
| 2500481 | XIIDRA 5% OPHTH DROPS | $874 | — | — | — | 0 |
| 24208091105 | XIIDRA 5% OPHTH (lifitegrast) dropperette | $874 | — | — | — | 0 |
| 2506192 | REGRANEX GEL 0.01% | $830 | — | — | — | 0 |
| 9180700 | PSYCH TESTING ASSESSMENT | $827 | — | — | — | 0 |
| 3000590 | HEAVY METALS PROFILE 1 | $821 | — | — | — | 0 |
| 9180200 | PSYCH TESTING-ADMIT-BEH | $742 | — | — | — | 0 |
| 9180650 | PSYCH TESTING-ABS-RC:2 | $742 | — | — | — | 0 |
| 3003520 | PROGRAF LEVEL | $730 | — | — | — | 0 |
| 2503700 | RISPERDAL INJ 37.5 MG/2 | $680 | — | — | — | 0 |
| 2506327 | MEGACE ES 625MG/5ML SUS | $669 | — | — | — | 0 |
| 3007902 | HEP C VIRAL RNA GENO 1 NS5A DRUG RESISTANT | $653 | — | — | — | 0 |
| 2506402 | ADVAIR DISK MIS 500/50 | $536 | — | — | — | 0 |
| 3007535 | HIV QT PCR (HIV 1 RNA PCR) | $516 | — | — | — | 0 |
| 2503853 | RISPERDAL INJ 25MG/2ML | $453 | — | — | — | 0 |
| 3007901 | HIV GENOTYPE SEQUENCEING | $450 | — | — | — | 0 |
| 5005881 | MMPI-2 | $440 | — | — | — | 0 |
| 5005882 | NEUROPSYCH. EVAL. 1 HR. | $439 | — | — | — | 0 |
| 9180550 | PSYCH TESTING-HRC20 | $430 | — | — | — | 0 |
| 9180600 | PSYCH TESTING-BNCE | $430 | — | — | — | 0 |
| 9180800 | CLINICAL FILE REVIEW | $430 | — | — | — | 0 |
| 3006235 | EXTRACTABLE NUCL ANTIGEN | $424 | — | — | — | 0 |
| 2507446 | VICTOZA INJ 18MG/3ML | $412 | — | — | — | 0 |
| 00480366719 | VICTOZA 18MG/3ML SUBQ PEN (LIRAGLUTIDE) | $412 | — | — | — | 0 |
| 2506246 | ADVAIR DISK NR MIS 250/50 | $406 | — | — | — | 0 |
| 3004403 | TESTOSTERONE LEVEL | $402 | — | — | — | 0 |
| 2507519 | NAYZILAM 5MG/0.1ML SOLN | $379 | — | — | — | 0 |
| 50474050015 | NAYZILAM 5MG/0.1ML SOLN | $379 | — | — | — | 0 |
| 2507098 | SYMBICORT 160/4.5MCG | $371 | — | — | — | 0 |
| 2506667 | XIBROM SOL 0.09% | $348 | — | — | — | 0 |
Showing top 50 of 3,100 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.